Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria: Management by General Practitioners in Bas-Rhin.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs
Study Overview
Brief Summary
Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult (≥18 years old)
- •Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
- •Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
- •The subject's primary care physician agreeing to participate in the study
Exclusion Criteria
- •Subject and/or their primary care physician having expressed their opposition to participating in the study
- •Subject under legal protection
- •Subject under guardianship or curatorship
Outcomes
Primary Outcomes
Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs
Time Frame: Up to 1 year
Prescription rates of appropriate antibiotics for the treatment of ESBL-E UTIs by general practitioners compared to current health authority recommendations
Secondary Outcomes
No secondary outcomes reported